Stock & Company Details
Lantheus Holdings Inc $LNTH
Price:
N/A
N/A
65M
$6.5B
52 Week High:
N/A
10 Day Average Volume:
N/A
24.22
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
LNTH technical indicators
Latest Lantheus Holdings Inc (LNTH) indicator readings as of 2026-10-09.
LNTH's 14-day RSI is 48.2, in neutral territory. At $100.15 it is trading 12.6% above its 200-day moving average of $88.92, and below its 50-day average of $100.47. Price sits in the middle of its Bollinger Bands ($99.34 to $100.82). ADX reads 14.6, indicating a range-bound market rather than a trend.
LNTH backtested strategy results
How 4 rule-based strategies performed on Lantheus Holdings Inc (LNTH) over recent history, last backtested 2026-09-05. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +46.6% | 44% | 9 | -30.4% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +182.6% | 27% | 26 | -36.9% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | +86.0% | 39% | 33 | -34.3% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +187.3% | 85% | 27 | -14.3% |
Overview
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Finance Bot
Ask your questions
Start by typing a question below.
